Daniel Lyons, Ph.D., CFA
投資組合經理 | 研究分析師
Daniel Lyons is a Portfolio Manager on the Health Care and Biotech Teams at Janus Henderson Investors, a role he has held since 2018. He is also a Research Analyst on the Healthcare team since 2000 and focuses on biotechnology and life science tools sectors. Daniel started consulting for Janus in 1997 and joined the research team full time in 2000.
Daniel以優異成績獲得萊斯大學生物化學及化學榮譽學士學位。他亦獲得史丹福大學的免疫學博士學位，其後跟隨科羅拉多大學一位諾貝爾獎得主進行博士後研究。他具備特許財務分析師的資格，在金融業界的工作經驗長達24年。
撰寫文章
生物科技板塊更新：力爭上游 (只提供英文版本)
Amid interest rate cuts and accelerating innovation, the biotechnology sector could be set up for strong performance.
